Vinzenz Hombach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vinzenz Hombach has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
M Kochs
24 shared publications- H.-H. Osterhues
Abteilung Innere Medizin II (Kardiologie, Angiologie, Pneumonologie, Nephrologie, Universität Ulm
10 shared publications M Höher
10 shared publicationsT Eggeling
Cardiology Clinic Haubrichforum, Cologne, Germany
6 shared publicationsC Felder
5 shared publicationsH H Hilger
4 shared publications
Latest Publications
- Open Access
- 22 May 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 25 (6) , 1136-1140
Magnetic resonance imaging to assess acute changes in atrial and ventricular parameters after transcatheter closure of atrial septal defects
Purpose: To evaluate acute changes in atrial and ventricular parameters by the use of cardiac magnetic resonance imaging (MRI) in patients with percutaneous transcatheter atrial septal defects (ASD) closure.Materials and Methods: The study included 14 patients (six males and eight females, 45 ± 18 years) with congenital ASD. Cardiac MRI (1.5T Philips Intera CV) was performed before and within 24 hours after transcatheter ASD closure. Right atrial (RA) and left atrial (LA) dimensions, as well as right (RV) and left (LV) ventricular end‐diastolic (ED) volumes were determined. Atrial size was assessed by planimetry of the maximum RA and LA areas in a standard four‐chamber view, and ventricular volumes were calculated according to a modified Simpson's rule in short‐axis views.Results: The mean RA decreased significantly from 27.6 ± 6.4 cm2 before closure to 24.4 ± 5.6 cm2 after the procedure (P = 0.0018), whereas the LA area did not change (24.1 ± 4.7 cm2 vs. 23.8 ± 5.2 cm2, P = 0.76). The RV volumes, volume index, and ejection fraction (EF) decreased significantly from 229 ± 64 mL to 181 ± 43 mL (P < 0.001, average reduction = 19% ± 15%), from 126.0 ± 37.2 mL/m2 to 96.6 ± 28.6 mL/m2 (P < 0.0001) and from 64 ± 5% to 58% ± 7% (P = 0.01), respectively. The LV volumes and volume index remained unchanged (114 ± 25 mL vs. 118 ± 22 mL, P = 0.18, 63.5 ± 13.5 mL/m2 vs. 63.0 ± 17.4 mL/m2, P = 0.83). Left–right shunting decreased from 40% ± 15% to 9% ± 15% (P < 0.001).Conclusion: Cardiac MRI can reveal detailed information on acute changes in shunt fraction and ventricular dimensions after ASD closure. ASD closure by percutaneous transcatheter device implantation results within 24 hours in a significant reduction of shunt fraction, RA and RV sizes, and RV function, whereas LA and LV dimensions remain unchanged. J. Magn. Reson. Imaging 2007;25:1136–1140.
- 22 May 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 25 (6) , 1136-1140
Open AccessMagnetic resonance imaging to assess acute changes in atrial and ventricular parameters after transcatheter closure of atrial septal defects
Purpose: To evaluate acute changes in atrial and ventricular parameters by the use of cardiac magnetic resonance imaging (MRI) in patients with percutaneous transcatheter atrial septal defects (ASD) closure.Materials and Methods: The study included 14 patients (six males and eight females, 45 ± 18 years) with congenital ASD. Cardiac MRI (1.5T Philips Intera CV) was performed before and within 24 hours after transcatheter ASD closure. Right atrial (RA) and left atrial (LA) dimensions, as well as right (RV) and left (LV) ventricular end‐diastolic (ED) volumes were determined. Atrial size was assessed by planimetry of the maximum RA and LA areas in a standard four‐chamber view, and ventricular volumes were calculated according to a modified Simpson's rule in short‐axis views.Results: The mean RA decreased significantly from 27.6 ± 6.4 cm2 before closure to 24.4 ± 5.6 cm2 after the procedure (P = 0.0018), whereas the LA area did not change (24.1 ± 4.7 cm2 vs. 23.8 ± 5.2 cm2, P = 0.76). The RV volumes, volume index, and ejection fraction (EF) decreased significantly from 229 ± 64 mL to 181 ± 43 mL (P < 0.001, average reduction = 19% ± 15%), from 126.0 ± 37.2 mL/m2 to 96.6 ± 28.6 mL/m2 (P < 0.0001) and from 64 ± 5% to 58% ± 7% (P = 0.01), respectively. The LV volumes and volume index remained unchanged (114 ± 25 mL vs. 118 ± 22 mL, P = 0.18, 63.5 ± 13.5 mL/m2 vs. 63.0 ± 17.4 mL/m2, P = 0.83). Left–right shunting decreased from 40% ± 15% to 9% ± 15% (P < 0.001).Conclusion: Cardiac MRI can reveal detailed information on acute changes in shunt fraction and ventricular dimensions after ASD closure. ASD closure by percutaneous transcatheter device implantation results within 24 hours in a significant reduction of shunt fraction, RA and RV sizes, and RV function, whereas LA and LV dimensions remain unchanged. J. Magn. Reson. Imaging 2007;25:1136–1140.
- 1 January 2007
- Vol. 46 (5) , 185-91
Patients with in-stent restenoses: comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stent.
We compared the intracoronary beta-brachytherapy using a liquid rhenium-188 filled balloon with the slow-release, polymer-based, paclitaxel-eluting Taxus-Express stent for treatment of in-stent restenoses. During the same study period, patients with restenoses in bare-metal stents were either treated with Taxus-Express stents (n = 50) or beta-brachytherapy after successful angioplasty (n = 51). For brachytherapy 30 Gy in 0.5 mm tissue depth were administered. The irradiated segment exceeded the traumatized segment 7.5 mm on both sides. Primary endpoint was the minimal lumen diameter (MLD) at the target lesion at six months follow-up. Angiographic follow-up was available in 78% (n = 79/101) and clinical follow-up in all patients. Baseline parameters did not differ statistically. The Taxus-Express stent resulted in a significantly larger MLD and a significantly lower percent diameter stenosis post intervention compared to beta-brachytherapy, which both maintained until angiographic follow-up (primary endpoint 2.44 +/- 0.74 mm versus 1.73 +/- 0.74 mm, p < 0.0001). Therefore, Taxus-Express stents were associated with a lower angiographic restenosis rate compared with beta-brachytherapy, both for the target lesion (6.1% versus 17.4%) and the total segment (9.1% versus 23.9%). Moreover, use of Taxus-stent was associated with a clinical benefit based on a significantly lower MACE rate compared with beta-brachytherapy (p < 0.05). Paclitaxel-eluting Taxus-Express stents resulted in superior clinical and angiographic outcomes compared to intracoronary beta-brachytherapy with a liquid (188)Re filled balloon for treatment of restenosis within a bare-metal stent.
- 1 January 2007
- Vol. 46 (5) , 185-91
Patients with in-stent restenoses: comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stent.
We compared the intracoronary beta-brachytherapy using a liquid rhenium-188 filled balloon with the slow-release, polymer-based, paclitaxel-eluting Taxus-Express stent for treatment of in-stent restenoses. During the same study period, patients with restenoses in bare-metal stents were either treated with Taxus-Express stents (n = 50) or beta-brachytherapy after successful angioplasty (n = 51). For brachytherapy 30 Gy in 0.5 mm tissue depth were administered. The irradiated segment exceeded the traumatized segment 7.5 mm on both sides. Primary endpoint was the minimal lumen diameter (MLD) at the target lesion at six months follow-up. Angiographic follow-up was available in 78% (n = 79/101) and clinical follow-up in all patients. Baseline parameters did not differ statistically. The Taxus-Express stent resulted in a significantly larger MLD and a significantly lower percent diameter stenosis post intervention compared to beta-brachytherapy, which both maintained until angiographic follow-up (primary endpoint 2.44 +/- 0.74 mm versus 1.73 +/- 0.74 mm, p < 0.0001). Therefore, Taxus-Express stents were associated with a lower angiographic restenosis rate compared with beta-brachytherapy, both for the target lesion (6.1% versus 17.4%) and the total segment (9.1% versus 23.9%). Moreover, use of Taxus-stent was associated with a clinical benefit based on a significantly lower MACE rate compared with beta-brachytherapy (p < 0.05). Paclitaxel-eluting Taxus-Express stents resulted in superior clinical and angiographic outcomes compared to intracoronary beta-brachytherapy with a liquid (188)Re filled balloon for treatment of restenosis within a bare-metal stent.
- Open Access
- 11 November 2005
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (11) , 1288
Cor triventriculare with pericardial aplasia and mitral valve prolapse: a novel congenital dysplastic syndrome?
A 37-year-old man was admitted to our hospital because of an apical abnormality, which was incidentally detected for the first time 10 years ago by echocardiography. The patient reported on normal physical activity and denied clinical signs of heart failure. His ECG showed antero-septal ST-segment alterations.
- 11 November 2005
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (11) , 1288
Open AccessCor triventriculare with pericardial aplasia and mitral valve prolapse: a novel congenital dysplastic syndrome?
A 37-year-old man was admitted to our hospital because of an apical abnormality, which was incidentally detected for the first time 10 years ago by echocardiography. The patient reported on normal physical activity and denied clinical signs of heart failure. His ECG showed antero-septal ST-segment alterations.
- 9 September 2005
- Published by Georg Thieme Verlag KG in Kardiologie up2date
- Vol. 1 (3) , 212-218
Gefäßwandimaging mittels Magnetresonanztomographie
Gefäßwanddarstellung. Will man den Grad der Atherosklerose an den für kardiovaskuläre Erkrankungen wichtigsten Gefäßen darstellen, so ist dies nichtinvasiv an den Karotiden mit dem hochauflösenden Ultraschall und - über den funktionellen Grad der Stenose - im Rahmen einer peripheren arteriellen Verschlusskrankheit (pAVK) möglich. Die Dokumentation der Atherosklerose an den Koronargefäßen gelingt dagegen nur indirekt mit der invasiven Koronarangiographie bzw. mit dem intravaskulären Ultraschall, also mit invasiven Verfahren. Auch das wahre Ausmaß atherosklerotischer Veränderungen der Aorta, der Iliakal- und der peripheren Arterien lässt sich nur angiographisch indirekt darstellen, wobei bisher in der klinischen Routine kein Imaging der Gefäßwand durchgeführt wird. In diesem Zusammenhang sind bildgebende, nichtinvasive Verfahren von höchstem Interesse, mit deren Hilfe man nicht nur eine Luminographie der betreffenden Gefäßprovinz erzielen kann, sondern besonders auch die Gefäßwände longitudinal oder im Querschnitt oder am besten sogar dreidimensional darstellen kann. Aus theoretischen Gründen ist dabei die Magnetresonanztomographie (MRT) mit ihrer hohen Weichteilauflösung, der sehr guten zeitlichen und recht guten örtlichen Auflösung, der fehlenden Strahlenbelastung und der extrem guten Kontrastmittelverträglichkeit die Methode der Wahl. Atherosklerotische Plaques. Die Hauptkomponenten einer atherosklerotischen Plaque sind: fibröse Elemente wie die bindegewebliche extrazelluläre Matrix (Kollagen, Proteoglykane) und Fibronektin, Lipide wie kristallines Cholesterin oder Cholesterinester und Phospholipide und inflammatorische Zellen (Makrophagen, T-Lymphozyten, glatte Muskelzellen). Nach den Kriterien der AHA sind an den Koronararterien besonders die vulnerablen Plaquetypen IV und Va relevant: Typ-IV-Läsionen bestehen aus extrazellulären Lipiden, vermischt mit fibrösem Gewebe, und sind durch eine fibröse Kappe abgedeckt, Typ-Va-Läsionen besitzen hauptsächlich einen extrazellulären Lipidkern mit einer dünnen fibrösen Kappe. Ein Einreißen von Typ-IV- oder -Va-Läsionen führt zur Bildung eines Thrombus oder einer komplizierten Typ-VI-Läsion, der Lipidkern ist hochthrombogen durch die Anwesenheit von Tissue Factor. Typ-IV- und -Va-Koronarläsionen sind wahrscheinlich bei bis zu 2 Drittel der Patienten die Ursache für ein instabiles Koronarsyndrom. Demgegenüber sind in den Karotisarterien die hochgradig stenotischen Plaques mit einem hohen Risiko vergesellschaftet, wobei diese Plaques nicht notwendigerweise lipidreich sind, sondern ein heterogenes Aussehen haben und viel Bindegewebe enthalten. Bei Ruptur solcher Hochrisikoplaques entwickelt sich ein intramurales Hämatom und eine Dissektion. Vulnerable Plaques in der Aorta sind nicht klassifiziert und von einer Mindestdicke von 4 mm. Die vulnerablen Plaques in der Aorta ähneln den Typ-IV- und Typ-Va-Plaques in den Koronararterien und sind dort möglicherweise ebenso gefährlich. So fand die French Aortic Plaque Study Group (FAPS) ein signifikant erhöhtes Risiko für alle vaskulären Ereignisse (Schlaganfall, Myokardinfarkt, periphere Embolien, kardiovaskulärer Tod) bei Patienten mit nicht kalzifizierten Aortenplaques mit einer Dicke von mehr als 4 mm [ 1 ].
- 9 September 2005
- Published by Georg Thieme Verlag KG in Kardiologie up2date
- Vol. 1 (3) , 212-218
Gefäßwandimaging mittels Magnetresonanztomographie
Gefäßwanddarstellung. Will man den Grad der Atherosklerose an den für kardiovaskuläre Erkrankungen wichtigsten Gefäßen darstellen, so ist dies nichtinvasiv an den Karotiden mit dem hochauflösenden Ultraschall und - über den funktionellen Grad der Stenose - im Rahmen einer peripheren arteriellen Verschlusskrankheit (pAVK) möglich. Die Dokumentation der Atherosklerose an den Koronargefäßen gelingt dagegen nur indirekt mit der invasiven Koronarangiographie bzw. mit dem intravaskulären Ultraschall, also mit invasiven Verfahren. Auch das wahre Ausmaß atherosklerotischer Veränderungen der Aorta, der Iliakal- und der peripheren Arterien lässt sich nur angiographisch indirekt darstellen, wobei bisher in der klinischen Routine kein Imaging der Gefäßwand durchgeführt wird. In diesem Zusammenhang sind bildgebende, nichtinvasive Verfahren von höchstem Interesse, mit deren Hilfe man nicht nur eine Luminographie der betreffenden Gefäßprovinz erzielen kann, sondern besonders auch die Gefäßwände longitudinal oder im Querschnitt oder am besten sogar dreidimensional darstellen kann. Aus theoretischen Gründen ist dabei die Magnetresonanztomographie (MRT) mit ihrer hohen Weichteilauflösung, der sehr guten zeitlichen und recht guten örtlichen Auflösung, der fehlenden Strahlenbelastung und der extrem guten Kontrastmittelverträglichkeit die Methode der Wahl. Atherosklerotische Plaques. Die Hauptkomponenten einer atherosklerotischen Plaque sind: fibröse Elemente wie die bindegewebliche extrazelluläre Matrix (Kollagen, Proteoglykane) und Fibronektin, Lipide wie kristallines Cholesterin oder Cholesterinester und Phospholipide und inflammatorische Zellen (Makrophagen, T-Lymphozyten, glatte Muskelzellen). Nach den Kriterien der AHA sind an den Koronararterien besonders die vulnerablen Plaquetypen IV und Va relevant: Typ-IV-Läsionen bestehen aus extrazellulären Lipiden, vermischt mit fibrösem Gewebe, und sind durch eine fibröse Kappe abgedeckt, Typ-Va-Läsionen besitzen hauptsächlich einen extrazellulären Lipidkern mit einer dünnen fibrösen Kappe. Ein Einreißen von Typ-IV- oder -Va-Läsionen führt zur Bildung eines Thrombus oder einer komplizierten Typ-VI-Läsion, der Lipidkern ist hochthrombogen durch die Anwesenheit von Tissue Factor. Typ-IV- und -Va-Koronarläsionen sind wahrscheinlich bei bis zu 2 Drittel der Patienten die Ursache für ein instabiles Koronarsyndrom. Demgegenüber sind in den Karotisarterien die hochgradig stenotischen Plaques mit einem hohen Risiko vergesellschaftet, wobei diese Plaques nicht notwendigerweise lipidreich sind, sondern ein heterogenes Aussehen haben und viel Bindegewebe enthalten. Bei Ruptur solcher Hochrisikoplaques entwickelt sich ein intramurales Hämatom und eine Dissektion. Vulnerable Plaques in der Aorta sind nicht klassifiziert und von einer Mindestdicke von 4 mm. Die vulnerablen Plaques in der Aorta ähneln den Typ-IV- und Typ-Va-Plaques in den Koronararterien und sind dort möglicherweise ebenso gefährlich. So fand die French Aortic Plaque Study Group (FAPS) ein signifikant erhöhtes Risiko für alle vaskulären Ereignisse (Schlaganfall, Myokardinfarkt, periphere Embolien, kardiovaskulärer Tod) bei Patienten mit nicht kalzifizierten Aortenplaques mit einer Dicke von mehr als 4 mm [ 1 ].
- Open Access
- 12 May 2005
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 5 (1) , 9
Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models
Background: Mycophenolate mofetil (MMF), the prodrug of mycophenolic acid (MPA), is a rationally designed immunosuppressive drug. The current study investigates the effect of MMF on key pattern of restenosis in a cascade of in vitro and ex vivo models. Methods: Part I of the study investigated in northern blot and cytoflow studies the effect of MMF (50, 100, 150, 200, 250, and 300 μg/mL) on TNF-α induced expression of intercellular adhesion molecule 1 (ICAM-1) in human coronary endothelial cells (HCAEC) and human coronary medial smooth muscle cells (HCMSMC). Part II of the study applied a human coronary 3D model of leukocyte attack, the 3DLA-model. HCAEC and HCMSMC were cultured on both sides of a polycarbonate filters, mimicking the internal elastic membrane. Leukocyte attack (LA) was carried out by adding human monocytes (MC) on the endothelial side. The effect of MMF (50 μg/mL) on adhesion and chemotaxis (0.5, 1, 2, 3, 4, 6, and 24 h after LA) and the effect on proliferation of co-cultured HCMSMC (24 h after LA) was studied. In part III of the study a porcine coronary organ culture model of restenosis (POC-model) was used. After ex vivo ballooning MMF (50 μg/mL) was added to the cultures for a period of 1, 2, 3, 4, 5, 6, and 7 days. The effect on reactive cell proliferation and neointimal thickening was studied at day 7 and day 28 after ballooning. Results: Expression of ICAM-1 in northern blot and cytoflow studies was neither clearly inhibited nor stimulated after administration of MMF in the clinical relevant concentration of 50 μg/mL. In the 3DLA-model 50 μg/mL of MMF caused a significant antiproliferative effect (p < 0.001) in co-cultured HCMSMC but had no effect on MC-adhesion and MC-chemotaxis. In the ex vivo POC-model neighter reactive cell proliferation at day 7 nor neointimal hyperplasia at day 28 were significantly inhibited by MMF (50 μg/mL). Conclusion: Thus, the data demonstrate a significant antiproliferative effect of clinical relevant levels of MMF (50 μg/mL) in the 3DLA-model. The antiproliferative effect was a direct antiproliferative effect that was not triggered via reduced expression of ICAM-1 or via an inhibition of MC-adhesion and chemotaxis. Probably due to technical limitations (as e.g. the missing of perfusion) the antiproliferative effect of MMF (50 μg/mL) could not be reproduced in the coronary organ culture model. A cascade of focused in vitro and ex vivo models may help to gather informations on drug effects before large experimental studies are initiated.
- 12 May 2005
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 5 (1) , 9
Open AccessEffects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models
Background: Mycophenolate mofetil (MMF), the prodrug of mycophenolic acid (MPA), is a rationally designed immunosuppressive drug. The current study investigates the effect of MMF on key pattern of restenosis in a cascade of in vitro and ex vivo models. Methods: Part I of the study investigated in northern blot and cytoflow studies the effect of MMF (50, 100, 150, 200, 250, and 300 μg/mL) on TNF-α induced expression of intercellular adhesion molecule 1 (ICAM-1) in human coronary endothelial cells (HCAEC) and human coronary medial smooth muscle cells (HCMSMC). Part II of the study applied a human coronary 3D model of leukocyte attack, the 3DLA-model. HCAEC and HCMSMC were cultured on both sides of a polycarbonate filters, mimicking the internal elastic membrane. Leukocyte attack (LA) was carried out by adding human monocytes (MC) on the endothelial side. The effect of MMF (50 μg/mL) on adhesion and chemotaxis (0.5, 1, 2, 3, 4, 6, and 24 h after LA) and the effect on proliferation of co-cultured HCMSMC (24 h after LA) was studied. In part III of the study a porcine coronary organ culture model of restenosis (POC-model) was used. After ex vivo ballooning MMF (50 μg/mL) was added to the cultures for a period of 1, 2, 3, 4, 5, 6, and 7 days. The effect on reactive cell proliferation and neointimal thickening was studied at day 7 and day 28 after ballooning. Results: Expression of ICAM-1 in northern blot and cytoflow studies was neither clearly inhibited nor stimulated after administration of MMF in the clinical relevant concentration of 50 μg/mL. In the 3DLA-model 50 μg/mL of MMF caused a significant antiproliferative effect (p < 0.001) in co-cultured HCMSMC but had no effect on MC-adhesion and MC-chemotaxis. In the ex vivo POC-model neighter reactive cell proliferation at day 7 nor neointimal hyperplasia at day 28 were significantly inhibited by MMF (50 μg/mL). Conclusion: Thus, the data demonstrate a significant antiproliferative effect of clinical relevant levels of MMF (50 μg/mL) in the 3DLA-model. The antiproliferative effect was a direct antiproliferative effect that was not triggered via reduced expression of ICAM-1 or via an inhibition of MC-adhesion and chemotaxis. Probably due to technical limitations (as e.g. the missing of perfusion) the antiproliferative effect of MMF (50 μg/mL) could not be reproduced in the coronary organ culture model. A cascade of focused in vitro and ex vivo models may help to gather informations on drug effects before large experimental studies are initiated.
- Open Access
- 15 February 2005
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (6) , 549-557
Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging
Aims Because of its high spatial resolution and tissue contrast, magnetic resonance imaging (MRI) was used to assess cardiac structure and function in a large population of patients with acute myocardial infarction (AMI). Methods and results One hundred and ten patients were studied by MRI 6.1±2.2 days after AMI. Infarct size (IS), persistent microvascular obstruction (PMO), left and right ventricular (LV/RV) volumes, and functions were measured. The same MRI measurements were repeated in 89 patients after a mean follow-up period of 225±92 days. IS was 11.9±7.3% of total LV muscle mass. PMO was detected in 51/110 (46.4%) patients and comprised 15.6±8.5% of IS and 2.8±2.3% of LV muscle mass. Papillary muscle infarct was seen in 26%, RV infarction in 16%, pericarditis in 40%, and pericardial effusion in 66% of the patients. During follow-up, there were 16 major adverse cardiac events (MACE) including seven deaths. IS, PMO, and amount of transmural infarction were predictive for LV adverse remodelling defined as >20% increase in LV end-diastolic volume. Multivariable analysis revealed LV end-diastolic volume, LV ejection fraction, and PMO as significant predictors for the occurrence of MACE. Conclusion MRI is a highly sensitive and reliable tool to detect morphologic and functional sequelae of AMI providing baseline MRI parameters with relevant predictive power for LV adverse remodelling and occurrence of MACE.
- 15 February 2005
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (6) , 549-557
Open AccessSequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging
Aims Because of its high spatial resolution and tissue contrast, magnetic resonance imaging (MRI) was used to assess cardiac structure and function in a large population of patients with acute myocardial infarction (AMI). Methods and results One hundred and ten patients were studied by MRI 6.1±2.2 days after AMI. Infarct size (IS), persistent microvascular obstruction (PMO), left and right ventricular (LV/RV) volumes, and functions were measured. The same MRI measurements were repeated in 89 patients after a mean follow-up period of 225±92 days. IS was 11.9±7.3% of total LV muscle mass. PMO was detected in 51/110 (46.4%) patients and comprised 15.6±8.5% of IS and 2.8±2.3% of LV muscle mass. Papillary muscle infarct was seen in 26%, RV infarction in 16%, pericarditis in 40%, and pericardial effusion in 66% of the patients. During follow-up, there were 16 major adverse cardiac events (MACE) including seven deaths. IS, PMO, and amount of transmural infarction were predictive for LV adverse remodelling defined as >20% increase in LV end-diastolic volume. Multivariable analysis revealed LV end-diastolic volume, LV ejection fraction, and PMO as significant predictors for the occurrence of MACE. Conclusion MRI is a highly sensitive and reliable tool to detect morphologic and functional sequelae of AMI providing baseline MRI parameters with relevant predictive power for LV adverse remodelling and occurrence of MACE.
- 20 January 2003
- Published by Institute of Electrical and Electronics Engineers (IEEE)
Feasibility study of complete neural net based classification of signal-averaged high-resolution ECGs
Classification of signal averaged ECGs is divided into two phases: (a) QRS-onset and QRS-offset determination and (b) categorization based on three derived features: QRS duration (QRSd), root mean square of the terminal 40 ms of the QRS (RMS) and the terminal low amplitude signal of the QRS below 40 /spl mu/V (LAS). Purpose of this feasibility study was the neural realization of each of these phases and the comparison of the different approaches. Both steps were realized with the neural network and the standard approach. Four combinations of the methods are possible. These were tested on 95 high-resolution signal averaged ECG recordings from 51 healthy volunteers and 44 patients with coronary artery disease. Using a neural network in the classification phase increased the sensitivity of the whole process by approximately 30% compared to the standard method without the need to visually correct the QRS-onset and-offsets. These initial results are very positive but need to be substantiated with further patient data.
- 20 January 2003
- Published by Institute of Electrical and Electronics Engineers (IEEE)
Feasibility study of complete neural net based classification of signal-averaged high-resolution ECGs
Classification of signal averaged ECGs is divided into two phases: (a) QRS-onset and QRS-offset determination and (b) categorization based on three derived features: QRS duration (QRSd), root mean square of the terminal 40 ms of the QRS (RMS) and the terminal low amplitude signal of the QRS below 40 /spl mu/V (LAS). Purpose of this feasibility study was the neural realization of each of these phases and the comparison of the different approaches. Both steps were realized with the neural network and the standard approach. Four combinations of the methods are possible. These were tested on 95 high-resolution signal averaged ECG recordings from 51 healthy volunteers and 44 patients with coronary artery disease. Using a neural network in the classification phase increased the sensitivity of the whole process by approximately 30% compared to the standard method without the need to visually correct the QRS-onset and-offsets. These initial results are very positive but need to be substantiated with further patient data.
- 1 September 2002
- Published by Springer Nature in Cardiac Electrophysiology Review
- Vol. 6 (3) , 209-214
Electrocardiogram of the Failing Heart
In the failing heart general specific (e.g., Q-waves after acute myocardial infarction, persistentST-elevations in post-myocardial infarction left ventricular aneurysm) and unspecific ECG changes...
- 1 September 2002
- Published by Springer Nature in Cardiac Electrophysiology Review
- Vol. 6 (3) , 209-214
Electrocardiogram of the Failing Heart
In the failing heart general specific (e.g., Q-waves after acute myocardial infarction, persistentST-elevations in post-myocardial infarction left ventricular aneurysm) and unspecific ECG changes...
- Open Access
- 18 January 2002
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 2 (1) , 1-10
Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: The peak of reactive cell proliferation as a hallmark for the duration of the treatment
Strictly intravascular approaches for the treatment of postangioplasty restenosis are effective in the intima and the inner parts of the media but may be insufficient to control redundant pathways in the more outer parts of the media and the adventitia. An inverse situation may occur subsequently to a strictly extravascular approach, like the recently suggested pericardial approach in pigs. We hypothesized that simultaneous intra/extravascular administration of anti-restenotic agents inhibits restenosis by blocking all stimulatory pathways in the entire arterial wall. Fresh hearts of 25 domestic pigs were obtained from a local slaughterhouse. Left anterior descending coronary arteries (LAD) were harvested, cut into cylindric 5 mm segments, and cultured as ex vivo porcine organ cultures (POCs). After 9 bar ballooning simultaneous intra/extravascular administration of high dose diltiazem (50 μg/mL) was carried out for a period of 1, 2, 3, 4, 5, 6, and 7 days. At day 7 and 28 proliferative activity (BrdU), neointimal thickening, and staining against smooth muscle α-actin and vWF was analysed. 7 days after ballooning administration of diltiazem for 4, 5, 6, and 7 days inhibited reactive cell proliferation by more than 50% (n.s.) as compared to control, 28 days after ballooning administration for 6 and 7 days inhibited neointimal thickening by more than 75% (p < 0.05). Simultaneous intra/extravascular administration of high dose diltiazem did not affect the expression of vWF in endothelial cells or smooth muscle α-actin in smooth muscle cells. Simultaneous intra/extravascular administration of high dose diltiazem (50 μg/mL) has to be maintained for at least 6 days to achieve a significant inhibition of neointimal thickening. The data demonstrate the importance of the maximal reactive cell proliferation (= day 7 in the POC-model) for the calculation of the duration of the treatment period.
- 18 January 2002
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 2 (1) , 1-10
Open AccessSimultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: The peak of reactive cell proliferation as a hallmark for the duration of the treatment
Strictly intravascular approaches for the treatment of postangioplasty restenosis are effective in the intima and the inner parts of the media but may be insufficient to control redundant pathways in the more outer parts of the media and the adventitia. An inverse situation may occur subsequently to a strictly extravascular approach, like the recently suggested pericardial approach in pigs. We hypothesized that simultaneous intra/extravascular administration of anti-restenotic agents inhibits restenosis by blocking all stimulatory pathways in the entire arterial wall. Fresh hearts of 25 domestic pigs were obtained from a local slaughterhouse. Left anterior descending coronary arteries (LAD) were harvested, cut into cylindric 5 mm segments, and cultured as ex vivo porcine organ cultures (POCs). After 9 bar ballooning simultaneous intra/extravascular administration of high dose diltiazem (50 μg/mL) was carried out for a period of 1, 2, 3, 4, 5, 6, and 7 days. At day 7 and 28 proliferative activity (BrdU), neointimal thickening, and staining against smooth muscle α-actin and vWF was analysed. 7 days after ballooning administration of diltiazem for 4, 5, 6, and 7 days inhibited reactive cell proliferation by more than 50% (n.s.) as compared to control, 28 days after ballooning administration for 6 and 7 days inhibited neointimal thickening by more than 75% (p < 0.05). Simultaneous intra/extravascular administration of high dose diltiazem did not affect the expression of vWF in endothelial cells or smooth muscle α-actin in smooth muscle cells. Simultaneous intra/extravascular administration of high dose diltiazem (50 μg/mL) has to be maintained for at least 6 days to achieve a significant inhibition of neointimal thickening. The data demonstrate the importance of the maximal reactive cell proliferation (= day 7 in the POC-model) for the calculation of the duration of the treatment period.
- 1 May 2001
- Published by Springer Nature in Die Innere Medizin
- Vol. 42 (5) , 649-658
Akuter Herzinfarkt: Epidemiologie und Prähospitalphase
- 1 May 2001
- Published by Springer Nature in Die Innere Medizin
- Vol. 42 (5) , 649-658
Akuter Herzinfarkt: Epidemiologie und Prähospitalphase